S.1497

Massachusetts S1497 aims to protect patient safety by regulating the labeling and distribution of non-FDA approved compounded medications.

Massachusetts S1497 establishes regulations for the labeling and distribution of compounded medications to ensure patient safety. It mandates specific labeling requirements for compounded drugs, including the identification of the drug as compounded, the outsourcing facility's details, and a statement that the drug is not for resale. The bill prohibits the resale of compounded drugs labeled "not for resale" and restricts the administration of drugs labeled "office use only" to the office setting.